Genentech’s Xeloda Is First Label Updated Under OCE’s ‘Project Renewal’

Capecitabine’s existing indications were revised and new indications added, reflecting uses that long have been considered standard of care; however, the cancer drug's label had been frozen in time since the approval of generics.